Institute for Health and Productvity Management, IHPM
Home Institute Info Academy for Health and Productivity Management Publications Join IHPM Initiative for Value-Based Health Benefits IHPM Awards Press Releases eNews

IHPM Annual International Conferences:

REGISTER: Login to your current IHPM Account by clicking on the "Account Login" link on the top right of this page. If you do not already have an IHPM Online Account, please CLICK HERE TO REGISTER

With an IHPM Account you can register for Conferences, update your contact and organizational information, as well as make publications purchases.

USA - Scottsdale, AZ & Orlando, FL

October 15th - 17th, 2008
Eighth Annual International Conference - Scottsdale, AZ
Click here for Details

Eighth Annual International Conference

Europe - Zurich, Switzerland

September 4-5, 2008
5th Annual European Health
and Productivity Congress

Click Here for Details

April 6-8, 2009
Fifth Annual Health Management Conference - Orlando, FL

Click Here for Details
Fifth Annual Health Management Conference

Journal of Health and Productivity
Journal of Health and Productivity

 

> Back to JHP Titles

The impact of Multiple Sclerosis on Patient Employment: A review of the medical literature

Susan L. Dennett, PhD, RPh; Jane Castelli-Haley, MBA; MerriKay Oleen-Burkey, PhD

1. Lage MJ, Castelli-Haley J, Oleen-Burkey MA. Effect of immunomodulatory therapy and other factors on employment loss time in multiple sclerosis.Work. 2006;27(2):143-51.

2. National Institute of Neurological Disorders and Stroke (NINDS). Multiple sclerosis: hope through research. NIH Publication No. 96-75. 2007. Accessed at http://www.ninds.nih.gov/disorders/multiple_sclerosis/multiple_sclerosis.htm on February 27, 2007.

3. Noonan CW, Kathman SJ, White MC. Prevalence estimates for MS in the United States and evidence of an increasing trend for women. Neurology 2002;58:136-8.

4. National Multiple Sclerosis Society. Overview of Multiple Sclerosis. 2006. Accessed at http://www.nationalmssociety.org/pdf/forpros/BasicFacts.pdf on December 22, 2006.

5. Richards RG, Sampson FC, Beard SM, Tappenden P. A review of the natural history and epidemiology of multiple sclerosis: implications for resource allocation and health economic models. Health Technol Assess 2002;6(10): 1-73.

6. National Multiple Sclerosis Society. National MS Society Information Sourcebook. Progressive disease. 2006. Accessed at http://main.nationalmssociety.org/docs/HOM/progressiveMS.pdf on March 29, 2007.

7. Bureau of Labor Statistics. Monthly labor review: the editor’s desk. States with highest unemployment rates in 2006. March 6, 2007. Accessed at http://www.bls.gov/opub/ted/2007/mar/wk1/art02.htm on March 8, 2007.

8. Beatty WW, Blanco CR, Wilbanks SL, Paul RH, Hames KA. Demographic, clinical, and cognitive characteristics of multiple sclerosis patients who continue to work. J Neuro Rehab 1995;9:167-73.

9. Kornblith AB, La Rocca NG, Baum HM. Employment in individuals with multiple sclerosis. Int J Rehabil Res. 1986;9(2):155-65.

10. Jackson MF, Quaal C, Reeves MA. Effects of multiple sclerosis on occupational and career patterns. Axone. 1991 Sep;13(1):16-7, 20-2.

11. Busche KD, Fisk JD, Murray TJ, Metz LM. Short term predictors of unemployment in multiple sclerosis patients. Can J Neurol Sci. 2003 May;30(2):137-42.

12. Gronning M, Hannisdal E, Mellgren SI. Multivariate analyses of factors associated with unemployment in people with multiple sclerosis. J Neurol Neurosurg Psychiatry. 1990 May;53(5):388-90.

13. O'Connor RJ, Cano SJ, Ramio i Torrenta L, Thompson AJ, Playford ED. Factors influencing work retention for people with multiple sclerosis: cross-sectional studies using qualitative and quantitative methods. J Neurol. 2005 Aug;252(8):892-6.

14. LaRocca N, Kalb R, Kendall P, Scheinberg L. The role of disease and demographic factors in the employment of patients with multiple sclerosis. Arch Neurol 1982;39(4):256.

15. Lauer K, Firnhaber W. Epidemiological investigations into multiple sclerosis in Southern Hesse. V. Course and prognosis. Acta Neurol Scand 1987;76(1):12-7.

16. Smith MM, Arnett PA. Factors related to employment status changes in individuals with multiple sclerosis. Mult Scler. 2005 Oct;11(5):602-9.

17. Chwastiak LA, Gibbons LE, Ehde DM, Sullivan M, Bowen JD, Bombardier CH, et al. Fatigue and psychiatric illness in a large community sample of persons with multiple sclerosis. J Psychosom Res. 2005 Nov;59(5):291-8.

18. Gulick EE, Yam M, Touw MM. Work performance by persons with multiple sclerosis: conditions that impede or enable the performance of work. Int J Nurs Stud. 1989;26(4):301-11.

19. Fisk JD, Pontefract A, Ritvo PG, Archibald CJ, Murray TJ. The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci. 1994 Feb;21(1):9-14.

20. Johnson KL, Yorkston KM, Klasner ER, Kuehn CM, Johnson E, Amtmann D. The cost and benefits of employment: a qualitative study of experiences of persons with multiple sclerosis. Arch Phys Med Rehabil. 2004 Feb;85(2):201-9.

21. Roessler RT, Rumrill PD Jr. Multiple sclerosis and employment barriers: a systemic perspective on diagnosis and intervention. Work. 2003;21(1):17-23.

22. Rao SM, Leo GJ, Ellington L, Nauertz T, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology. 1991 May;41(5):692-6.

23. Wild KV, Lezak MD, Whitham RH, Bourdette DN. Psychosocial impact of cognitive impairment in the multiple sclerosis patient. J Clin Exp Neuropsych 1991;13:74.

24. Mohr DC, Cox D. Multiple sclerosis: empirical literature for the clinical health psychologist. J Clin Psychol. 2001 Apr;57(4):479-99.

25. Williams RM, Turner AP, Hatzakis Jr. M, Bowen JD, Rodriquez AA, Haselkorn JK. Prevalence and correlates of depression among veterans with multiple sclerosis. Neurology 2005;64:75–80.

26. Gilchrist AC, Creed FH. Depression, cognitive impairment and social stress in multiple sclerosis. J Psychosom Res. 1994 Apr;38(3):193-201.

27. Chwastiak L, Ehde DM, Gibbons LE, Sullivan M, Bowen JD, Kraft GH. Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample. Am J Psychiatry. 2002 Nov;159(11):1862-8.

28. Patten SB, Beck CA, Williams JV, Barbui C, Metz LM. Major depression in multiple sclerosis: a population-based perspective. Neurology. 2003 Dec 9;61(11):1524-7.

29. Minden SL, Orav J, Reich P. Depression in multiple sclerosis. Gen Hosp Psychiatry. 1987 Nov;9(6):426-34.

30. Sadovnick AD, Remick RA, Allen J, Swartz E, Yee IM, Eisen K, et al. Depression and multiple sclerosis. Neurology. 1996 Mar;46(3):628-32.

31. Verdier-Taillefer MH, Sazdovitch V, Borgel F, Cesaro P, Kurtz A, Millet MF, et al. Occupational environment as risk factor for unemployment in multiple sclerosis. Acta Neurol Scand. 1995 Jul;92(1):59-62.

32. Dyck I, Jongbloed L. Women with multiple sclerosis and employment issues: a focus on social and institutional environments. Can J Occup Ther. 2000 Dec;67(5):337-46.

33. Johnson KL, Amtmann D, Yorkston KM, Klasner ER, Kuehn CM. Medical, psychological, social, and programmatic barriers to employment for people with multiple sclerosis. J Rehabil 2004;70: 38-50.

34. Miller A, Dishon S. Health-related quality of life in multiple sclerosis: The impact of disability, gender and employment status. Qual Life Res. 2006 Mar;15(2):259-71.

35. Hermann BP, Vickrey B, Hays RD, Cramer J, Devinsky O, Meador K, et al. A comparison of health-related quality of life in patients with epilepsy, diabetes and multiple sclerosis. Epilepsy Res. 1996 Oct;25(2):113-8.

36. Riazi A, Hobart JC, Lamping DL, Fitzpatrick R, Freeman JA, Jenkinson C, et al. Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson's disease with normal population health profiles. J Neurol Neurosurg Psychiatry. 2003 Jun;74(6):710-4.

37. Simone IL, Ceccarelli A, Tortorella C, Bellacosa A, Pellegrini F, Plasmati I, et al. Influence of Interferon beta treatment on quality of life in multiple sclerosis patients. Health Qual Life Outcomes. 2006 Dec 12;4(1):96 [Epub ahead of print].

38. Janardhan V, Bakshi R. Quality of life in patients with multiple sclerosis: the impact of fatigue and depression. J Neurol Sci. 2002 Dec 15;205(1):51-8.

39. Gulick EE. Correlates of quality of life among persons with multiple sclerosis. Nurs Res. 1997 Nov-Dec;46(6):305-11.

40. Aronson KJ. Quality of life among persons with multiple sclerosis and their caregivers. Neurology. 1997 Jan;48(1):74-80.

41. Sibley WA. Risk factors in multiple sclerosis. In CS Raine, HF McFarland, and WW Tourtellotte (Eds.), Multiple sclerosis: Clinical and pathogenetic basis (pp. 141-8). 1997. London: Chapman & Hall.

42. Johnson KL, Fraser RT.. Mitigating the impact of multiple sclerosis on employment. Phys Med Rehabil Clin N Am. 2005 May;16(2):571-82.

43. Metz LM, Patten SB, Archibald CJ, Bakker JI, Harris CJ, Patry DG, et al. The effect of immunomodulatory treatment on multiple sclerosis fatigue. J Neurol Neurosurg Psychiatry 2004;75(7):1045-7.

44. LaBan MM, Martin T, Pechur J, Sarnacki S. Physical and occupational therapy in the treatment of patients with multiple sclerosis. Phys Med Rehabil Clin N Am. 1998 Aug;9(3):603-14.

45. Wiles CM, Newcombe RG, Fuller KJ, Shaw S, Furnival-Doran J, Pickersgill TP, et al. Controlled randomised crossover trial of the effects of physiotherapy on mobility in chronic multiple sclerosis. J Neurol Neurosurg Psychiatry. 2001 Feb;70(2):174-9.

46. Rasova K, Havrdova E, Brandejsky P, Zalisova M, Foubikova B, Martinkova P. Comparison of the influence of different rehabilitation programmes on clinical, spirometric and spiroergometric parameters in patients with multiple sclerosis. Mult Scler. 2006 Apr;12(2):227-34.

47. Kesselring J, Beer S. Symptomatic therapy and neurorehabilitation in multiple sclerosis. Lancet Neurology 2005;4(10:643-52.

48. Steultjens EM, Dekker J, Bouter LM, Jellema S, Bakker EB, van den Ende CH. Occupational therapy for multiple sclerosis. The Cochrane Library 2006;4: 1-23.

Bagert B, Camplair P, Bourdette D. Cognitive dysfunction in multiple s

49. clerosis: natural history, pathophysiology and management. CNS Drugs. 2002;16(7):445-55.

© 2008 All Rights Reserved, Institute for Health and Productivity Management